Showing results (2171-2180 of 2,313) with videos related to

Sort By:
Pageof 232
Cardiovascular Research|December 11, 2013
Thrombomodulin's lectin-like domain reduces myocardial damage by interfering with HMGB1-mediated TLR2 signallingChristine Herzog, Anika Lorenz, Hans-Jörg Gillmann, et al.
Science Advances|May 1, 2024
D-peptide-magnetic nanoparticles fragment tau fibrils and rescue behavioral deficits in a mouse model of Alzheimer's diseaseKe Hou, Hope Pan, Hedieh Shahpasand-Kroner, et al.
BMJ Open|December 5, 2020
Comprehensive database and individual patient data meta-analysis of randomised controlled trials on psychotherapies reducing suicidal thoughts and behaviour: study protocolMandy Xian Hu, Christina Palantza, Kim Setkowski, et al.
Journal of Occupational Medicine and Toxicology (London, England)|June 16, 2020
Cardiovascular health outcomes of mobbing at work: results of the population-based, five-year follow-up of the Gutenberg health studyKarla Romero Starke, Janice Hegewald, Andreas Schulz, et al.
Pflugers Archiv : European Journal of Physiology|September 2, 2008
Defective jejunal and colonic salt absorption and alteredNa(+)/H (+) exchanger 3 (NHE3) activity in NHE regulatory factor 1 (NHERF1) adaptor protein-deficient miceN Broere, M Chen, A Cinar, et al.
Nature Communications|September 15, 2025
A polycyclic scaffold identified by structure-based drug design effectively inhibits the human P2X7 receptorAdam C Oken, Andreea L Turcu, Eva Tzortzini, et al.
JACC. Heart Failure|January 4, 2024
Mavacamten Treatment for Symptomatic Obstructive Hypertrophic Cardiomyopathy: Interim Results From the MAVA-LTE Study, EXPLORER-LTE CohortFlorian Rader, Artur Oręziak, Lubna Choudhury, et al.
Plos One|September 27, 2021
Correction: Work-life conflict and cardiovascular health: 5-year follow-up of the Gutenberg Health StudyJanice Hegewald, Karla Romero Starke, Susan Garthus-Niegel, et al.
International Archives of Occupational and Environmental Health|October 27, 2020
Self-reported cardiovascular health of teachers: results from the 5-year follow-up of the Gutenberg Health Study cohortMerle Riechmann-Wolf, Sylvia Jankowiak, Andreas Schulz, et al.
Gastroenterology|March 20, 2025
Efficacy and Safety of Guselkumab Subcutaneous Induction and Maintenance in Participants With Moderately to Severely Active Crohn's Disease: Results From the Phase 3 GRAVITI StudyAilsa Hart, Remo Panaccione, Flavio Steinwurz, et al.
Pageof 232